ATE319699T1 - Mannitol- und glucitolderivate - Google Patents

Mannitol- und glucitolderivate

Info

Publication number
ATE319699T1
ATE319699T1 AT03028655T AT03028655T ATE319699T1 AT E319699 T1 ATE319699 T1 AT E319699T1 AT 03028655 T AT03028655 T AT 03028655T AT 03028655 T AT03028655 T AT 03028655T AT E319699 T1 ATE319699 T1 AT E319699T1
Authority
AT
Austria
Prior art keywords
mannitol
glucitol derivatives
oligomeric compounds
glucitol
derivatives
Prior art date
Application number
AT03028655T
Other languages
English (en)
Inventor
Frank Dr Bergmann
Der Eltz Herbert Dr Von
Christoph Dr Seidel
Kurt Dr Weindel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP02028714A external-priority patent/EP1431297A1/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE319699T1 publication Critical patent/ATE319699T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicinal Preparation (AREA)
AT03028655T 2002-12-20 2003-12-16 Mannitol- und glucitolderivate ATE319699T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02028714A EP1431297A1 (de) 2002-12-20 2002-12-20 Mannitol- und Glucitolderivate
US44021203P 2003-01-15 2003-01-15
EP03001215 2003-01-20

Publications (1)

Publication Number Publication Date
ATE319699T1 true ATE319699T1 (de) 2006-03-15

Family

ID=32600614

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03028655T ATE319699T1 (de) 2002-12-20 2003-12-16 Mannitol- und glucitolderivate

Country Status (7)

Country Link
EP (1) EP1431298B1 (de)
JP (1) JP4169689B2 (de)
CN (1) CN1513849B (de)
AT (1) ATE319699T1 (de)
CA (1) CA2453382C (de)
DE (1) DE60303865T2 (de)
ES (1) ES2260569T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010060599A1 (en) 2008-11-27 2010-06-03 Roche Diagnostics Gmbh Directed synthesis of oligophosphoramidate stereoisomers
WO2011034605A2 (en) 2009-09-16 2011-03-24 Genentech, Inc. Coiled coil and/or tether containing protein complexes and uses thereof
AR080793A1 (es) 2010-03-26 2012-05-09 Roche Glycart Ag Anticuerpos biespecificos
JP5766296B2 (ja) 2010-12-23 2015-08-19 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft ポリペプチド−ポリヌクレオチド複合体、およびエフェクター成分の標的化された送達におけるその使用
EP2655414B1 (de) 2010-12-23 2018-08-29 Roche Diagniostics GmbH Bispezifisches bindungsmolekül
CN103384825B (zh) 2010-12-23 2017-05-24 霍夫曼-拉罗奇有限公司 通过二价结合剂检测经翻译后修饰的多肽
MX2014009565A (es) 2012-02-10 2014-11-10 Genentech Inc Anticuerpos monocatenarios y otros heteromultimeros.
JP6203838B2 (ja) 2012-06-27 2017-09-27 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 少なくとも2つの異なる結合実体を含む、テーラーメイドの高度に選択的かつ多重特異的なターゲティング実体を選択および作製するための方法、ならびにその使用
RU2015100656A (ru) 2012-06-27 2016-08-20 Ф. Хоффманн-Ля Рош Аг Способ получения конъюгатов fc-фрагмента антитела, включающих по меньшей мере одну связывающую группировку, которая специфически связывается с мишенью, и их применения
WO2016087416A1 (en) 2014-12-03 2016-06-09 F. Hoffmann-La Roche Ag Multispecific antibodies
WO2018013999A1 (en) 2016-07-15 2018-01-18 Am Chemicals Llc Non-nucleosidic solid supports and phosphoramidite building blocks for oligonucleotide synthesis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005213A1 (en) * 1994-08-17 1996-02-22 Stichting Rega Vzw Sequence-specific binding oligomers for nucleic acids and their use in antisense strategies
DE10044373A1 (de) * 2000-09-08 2002-03-21 Roche Diagnostics Gmbh Neues Reagenz zur Markierung von Nukleinsäuren

Also Published As

Publication number Publication date
CN1513849B (zh) 2013-03-27
JP2004203878A (ja) 2004-07-22
EP1431298B1 (de) 2006-03-08
CN1513849A (zh) 2004-07-21
EP1431298A1 (de) 2004-06-23
DE60303865D1 (de) 2006-05-04
CA2453382C (en) 2009-04-07
JP4169689B2 (ja) 2008-10-22
DE60303865T2 (de) 2006-09-21
ES2260569T3 (es) 2006-11-01
HK1066222A1 (en) 2005-03-18
CA2453382A1 (en) 2004-06-20

Similar Documents

Publication Publication Date Title
DE502004010433D1 (de) Prozeß zur Herstellung von Aryl- oder Heteroarylamin-Boronsäurederivaten
ATE381552T1 (de) Derivate von 1-piperazin- und 1- homopiperazincarboxylaten, verfahren zu deren herstellung und deren verwendung als inhibitoren des faah-enzyms
DK1831362T3 (da) Syreaktive svampeproteaser
ATE417127T1 (de) Nukelinsäuresequenzbestimmung mittels elektronischem nachweis
NO20044290L (no) Fremgangsmate for forbedring av boredybdemalinger
DE60308596D1 (de) Verfahren zur Herstellung von anorganisichen Nanoröhren
EP1943348A4 (de) Zusammensetzungen, verfahren und kits zur amplifikation von nukleinsäuren
CY1111771T1 (el) Ενζυμα τα οποια εχουν δραστικοτητα αλφα αμυλασης και μεθοδοι χρησεις τους
ATE534629T1 (de) Verfahren und verbindungen zur herstellung von cc-1065-analoga
DE602005015834D1 (de) 3,4-(cyclopentyl)kondensierte prolinverbindungen als inhibitoren der ns3-serinprotease des hepatitis-c-virus
WO2003004614A3 (en) Identification and use of conserved noncoding sequences
ATE396731T1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
AU2001244677A1 (en) Method of amplifying nucleic acid by using double-stranded nucleic acid as template
BR0308452A (pt) composições farmacêuticas e métodos de preparação de composição farmacêutica
ATE319699T1 (de) Mannitol- und glucitolderivate
DE60235005D1 (de) Nachweis der instabilität von mikrosatelliten und
DE60108042D1 (de) Prozesse zur Herstellung von pulverförmigen Schlagzäh-Modifizierern
DE60307710D1 (de) Verfahren zur Herstellung von Eisenoxiden
NO20033682D0 (no) Epothilone-derivater for behandling av refraktor-tumorer
NO20053206D0 (no) Fremgangsmate for produsering av ketokarotenoider ved dyrking av genetisk modifiserte organismer.
DE602005020062D1 (de) Lyophilisierung von virosomen
DE602004006118D1 (de) 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER
BRPI0408117A (pt) compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos
DE502004009152D1 (de) Verfahren zur herstellung von derivaten des 4a,5,9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1431298

Country of ref document: EP